These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1850995

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST, Wilcox RA, Liu C, Dubreuil D, Potter BV, Nahorski SR.
    Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
    [Abstract] [Full Text] [Related]

  • 5. Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes.
    Hirata M, Watanabe Y, Yoshida M, Koga T, Ozaki S.
    J Biol Chem; 1993 Sep 15; 268(26):19260-6. PubMed ID: 8396130
    [Abstract] [Full Text] [Related]

  • 6. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT, Bullock AJ, Lindley CJ, Mills SJ, Riley AM, Potter BV, Westwick J.
    Mol Pharmacol; 1996 Nov 15; 50(5):1223-30. PubMed ID: 8913354
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT, Riley AM, Lindley CJ, Jenkins DJ, Westwick J, Potter BV.
    Mol Pharmacol; 1997 Oct 15; 52(4):741-8. PubMed ID: 9380038
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Conformational changes in plant Ins(1,4,5)P3 receptor on interaction with different myo-inositol trisphosphates and its effect on Ca2+ release from microsomal fraction and liposomes.
    Dasgupta S, Dasgupta D, Chatterjee A, Biswas S, Biswas BB.
    Biochem J; 1997 Jan 15; 321 ( Pt 2)(Pt 2):355-60. PubMed ID: 9020866
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site.
    Lu PJ, Gou DM, Shieh WR, Chen CS.
    Biochemistry; 1994 Sep 27; 33(38):11586-97. PubMed ID: 7918372
    [Abstract] [Full Text] [Related]

  • 14. Characterization of two forms of inositol 1,4,5-trisphosphate receptor in rat liver.
    Pietri F, Hilly M, Claret M, Mauger JP.
    Cell Signal; 1990 Sep 27; 2(3):253-63. PubMed ID: 2169293
    [Abstract] [Full Text] [Related]

  • 15. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase.
    Safrany ST, Sawyer D, Wojcikiewicz RJ, Nahorski SR, Potter BV.
    FEBS Lett; 1990 Dec 10; 276(1-2):91-4. PubMed ID: 2176165
    [Abstract] [Full Text] [Related]

  • 16. Involvement of the C-terminus of the inositol 1,4,5-trisphosphate receptor in Ca2+ release analysed using region-specific monoclonal antibodies.
    Nakade S, Maeda N, Mikoshiba K.
    Biochem J; 1991 Jul 01; 277 ( Pt 1)(Pt 1):125-31. PubMed ID: 1713032
    [Abstract] [Full Text] [Related]

  • 17. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA, Erneux C, Primrose WU, Gigg R, Nahorski SR.
    Mol Pharmacol; 1995 Jun 01; 47(6):1204-11. PubMed ID: 7603461
    [Abstract] [Full Text] [Related]

  • 18. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA, Fauq A, Kozikowski AP, Nahorski SR.
    FEBS Lett; 1997 Feb 03; 402(2-3):241-5. PubMed ID: 9037203
    [Abstract] [Full Text] [Related]

  • 19. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M, Narumoto N, Watanabe Y, Kanematsu T, Koga T, Ozaki S.
    Mol Pharmacol; 1994 Feb 03; 45(2):271-6. PubMed ID: 8114676
    [Abstract] [Full Text] [Related]

  • 20. Interactions between inositol tris- and tetrakis-phosphates. Effects on intracellular Ca2+ mobilization in SH-SY5Y cells.
    Gawler DJ, Potter BV, Gigg R, Nahorski SR.
    Biochem J; 1991 May 15; 276 ( Pt 1)(Pt 1):163-7. PubMed ID: 1645528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.